BioNTech CEO Ugur Sahin sells ordinary shares worth $7.86 million

• BioNTech CEO Ugur Sahin sold 76,500 ordinary shares on Sept. 3-4, 2026, trimming his stake to 781,709 shares.
• Sales priced at USD 102.85 to USD 103.52 per share.
• Transactions executed under a Rule 10b5-1 trading plan adopted on June 3, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BioNTech SE published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002123975-26-000008), on September 08, 2026, and is solely responsible for the information contained therein.